EP08.02-135 Anti-EGF Antibodies Significantly Improve the Activity of MET and KRAS Inhibitors in Preclinical Models of Non-small Cell Lung Cancer (NSCLC).
- Resource Type
- Article
- Source
- Journal of Thoracic Oncology; 2022 Supplement, Vol. 17 Issue 9, pS467-S467, 1p
- Subject
- Language
- ISSN
- 15560864